Buy Pieris Pharma Stock | PIRS Stock Price & Latest News | Public
PIRS

Pieris Pharma

$0.00 (0.00%)Today
    Small Market Cap

    About PIRS

    Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Scha...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.09
    -0.18
    -0.26
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.23

    Actual EPS
    Q4 2020

    Stats

    Market Cap$157,83M
    Volume10,22k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.30
    1 Year Low$1.60
    Open$2.84
    High$2.99
    Low$2.80

    Buy any stock with any amount of money.

    Download the App
    Download the app